+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Asparaginase"

From
From
From
From
From
From
From
From
From
From
From
From
Investigation Report on China's Pegaspargase Market, 2019-2023 - Product Thumbnail Image

Investigation Report on China's Pegaspargase Market, 2019-2023

  • Report
  • September 2019
  • 30 Pages
  • China
From
From
Enzymes in Food Technology. Edition No. 2 - Product Thumbnail Image

Enzymes in Food Technology. Edition No. 2

  • Book
  • November 2009
  • 384 Pages
  • 19 Results (Page 1 of 1)
Loading Indicator

Asparaginase is a type of drug used to treat leukemia, a type of cancer. It works by breaking down the amino acid asparagine, which is essential for the growth of cancer cells. Asparaginase is used in combination with other chemotherapy drugs to treat acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It is also used to treat non-Hodgkin's lymphoma and other types of cancer. Asparaginase is available in both injectable and oral forms. The injectable form is usually given intravenously, while the oral form is taken as a pill. The asparaginase market is highly competitive, with several companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Other companies include Amgen, Teva Pharmaceuticals, and Eli Lilly. Show Less Read more